Persistent Readiness Through Early Prediction Immunization Study

NCT05346302 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

249

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Response

Interventions

DRUG: Pneumovax 23
DRUG: Typhim VI
OTHER: Saline

Sponsor

Texas A&M University

Collaborators

[object Object]
[object Object]